A Two Phase, Double-blinded, Randomized, Parallel Group Design, Multicenter Study of FLOMAX Capsules, 0.4 mg Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia

Trial Profile

A Two Phase, Double-blinded, Randomized, Parallel Group Design, Multicenter Study of FLOMAX Capsules, 0.4 mg Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2014

At a glance

  • Drugs Tamsulosin (Primary)
  • Indications Urinary retention
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 25 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top